Doxorubicin: all 842 studies that test it
Page 4 of 9. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
- Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast CancerCompletedNCT00193037Phase 2Results posted
- Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast CancerCompletedNCT00191789Phase 2Results posted
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's LymphomasCompletedNCT00184002Phase 2Results posted
- Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerCompletedNCT00182767Phase 1/2Results posted
- Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian CancerCompletedNCT00170573Phase 2Results posted
- Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple MyelomaCompletedNCT00148317Phase 2Results posted
- Therapy for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00137111Phase 3Results posted
- Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00129376Phase 2Results posted
- Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell LymphomaCompletedNCT00121199Phase 2Results posted
- Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerCompletedNCT00119262Phase 2Results posted
- S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00109837Phase 2Results posted
- A Research Study to Treat Patients With Advanced Hepatocellular CarcinomaCompletedNCT00108953Phase 2Results posted
- S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00107380Phase 2Results posted
- Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin DiseaseCompletedNCT00107198Phase 2Results posted
- Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple MyelomaCompletedNCT00103506Phase 3Results posted
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00103285Phase 3Results posted
- Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell LymphomaCompletedNCT00101101Phase 2Results posted
- Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell LymphomaCompletedNCT00101010Phase 2Results posted
- A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00097981Phase 3Results posted
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)CompletedNCT00094497Phase 3Results posted
- A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast CancerCompletedNCT00091442Phase 3Results posted
- Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RTCompletedNCT00084838Phase 2Results posted
- DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE ConsolidationCompletedNCT00083915Phase 3Results posted
- UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation ChemotherapyCompletedNCT00083551Phase 3Results posted
- Doxorubicin and Bortezomib in Treating Patients With Liver CancerCompletedNCT00083226Phase 2Results posted
- Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph CancersTerminatedNCT00074490Phase 2Results posted
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerActive, not recruitingNCT00070564Phase 3Results posted
- S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaCompletedNCT00070018Phase 2Results posted
- Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaCompletedNCT00068393Phase 2Results posted
- Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerTerminatedNCT00063934Phase 1/2Results posted
- Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric SarcomasCompletedNCT00043979Phase 2Results posted
- Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast CancerCompletedNCT00041119Phase 3Results posted
- Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerTerminatedNCT00024167Phase 3Results posted
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00021255Phase 3Results posted
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerCompletedNCT00014222Phase 3Results posted
- Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple MyelomaCompletedNCT00006184Phase 2Results posted
- Combination Chemotherapy in Treating Patients With High-Risk Breast CancerCompletedNCT00004092Phase 2Results posted
- Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the LiverCompletedNCT00003907Phase 2Results posted
- S9912 Combination Chemo in Stage III Ovarian Cancer,CompletedNCT00003896Phase 2Results posted
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With SarcomaCompletedNCT00002601Phase 2Results posted
- Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)Active, not recruitingNCT07109414Phase 2/3
- Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaSuspendedNCT06738368Phase 2
- Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast CancerCompletedNCT06098599Phase 1
- To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLActive, not recruitingNCT06072131Phase 3
- PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin LymphomaActive, not recruitingNCT05922904Phase 2
- Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaActive, not recruitingNCT05864534Phase 2
- Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBCActive, not recruitingNCT05645380Phase 2
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)Active, not recruitingNCT05630209Phase 1/2
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPGActive, not recruitingNCT05615623Phase 1/2
- Doxil/Caelyx BE StudyCompletedNCT05567601Phase 1
- Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian CancerActive, not recruitingNCT05467670Phase 2
- Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic LeukemiaActive, not recruitingNCT05453500Phase 2
- YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic SarcomaActive, not recruitingNCT05448820Phase 1/2
- A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)Active, not recruitingNCT05406401Phase 2
- Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBCStatus unknownNCT05386524Phase 2
- Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in VivoStatus unknownNCT05354076Phase 2
- A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast CancerActive, not recruitingNCT05275777Phase 1/2
- Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese PatientsStatus unknownNCT05273944Phase 1
- Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.Active, not recruitingNCT05271318Phase 1/2
- A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell LymphomaStatus unknownNCT05200312Phase 2
- A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaStatus unknownNCT05138146Phase 2
- Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of ChemotherapyStatus unknownNCT05097248Phase 2
- Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.Status unknownNCT05049473Phase 2
- A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8)WithdrawnNCT04974996Phase 1
- A Study of N9 Chemotherapy in Children With NeuroblastomaActive, not recruitingNCT04947501Early Phase 1
- A Study to Evaluate the Combination of ATX-101 and Platinum-based ChemotherapyTerminatedNCT04814875Phase 1/2
- A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)TerminatedNCT04790903Phase 1
- A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue SarcomaTerminatedNCT04780464Phase 3
- Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue SarcomaStatus unknownNCT04765228Phase 2
- The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast CancerStatus unknownNCT04753177Phase 2/3
- Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell LymphomaWithdrawnNCT04639843Phase 1
- Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsActive, not recruitingNCT04530565Phase 3
- Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell LymphomaActive, not recruitingNCT04480099Phase 2
- Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated LymphomaActive, not recruitingNCT04479267Phase 2
- A Bioequivalence Study of Doxorubicin Hydrochloride Liposome InjectionCompletedNCT04460820Not applicable
- The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaStatus unknownNCT04356872Phase 2
- Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian CancerStatus unknownNCT04337632Phase 3
- Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid CarcinomaCompletedNCT04224337Phase 2
- Heated Intra-peritoneal Chemotherapy with Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTerminatedNCT04213794Early Phase 1
- DCV in the Treatment of Recurrence and Refractory Childhood Solid TumorsStatus unknownNCT04213612Phase 1
- Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid SarcomaTerminatedNCT04204941Phase 1
- L-DOS47 Plus Doxorubicin in Advanced Pancreatic CancerTerminatedNCT04203641Phase 1/2
- ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBCActive, not recruitingNCT04172259Phase 2
- Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder CancerStatus unknownNCT04101812Phase 2
- A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerActive, not recruitingNCT04092270Phase 1
- Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast CancerActive, not recruitingNCT04083963Phase 2
- Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.Status unknownNCT04077905Phase 3
- Adjuvant PIPAC in Gastric Cancer PatientsCompletedNCT04047004Phase 1
- COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerWithdrawnNCT04038489Phase 2
- Dose Finding Study of L19TNF and Doxorubicin in Patients With STSActive, not recruitingNCT04032964Phase 1
- Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue SarcomaStatus unknownNCT04012827Phase 2
- Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast CancerStatus unknownNCT03994107Phase 1/2
- Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaCompletedNCT03991884Phase 1
- To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time FramesStatus unknownNCT03975205Early Phase 1
- Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerActive, not recruitingNCT03971409Phase 2
- Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell LymphomaStatus unknownNCT03952572Phase 3
- Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)Status unknownNCT03949634Phase 3
- Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast CancerStatus unknownNCT03933319Phase 2
- A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's SyndromeActive, not recruitingNCT03899337Phase 2